Central Pacific Financial Corp. operates as the bank holding company for Central Pacific Bank that provides a range of commercial banking products and services to businesses, professionals, and individuals in the United States. The company offers various deposit products and services, including checking, savings and time deposits, cash management and digital banking, trust, and retail brokerage services, as well as money market accounts and certificates of deposit. It also provides various lending activities, such as commercial, commercial and residential mortgage, home equity, and consumer loans; and other products and services comprising debit cards, internet and mobile banking, cash management services, full-service ATMs, safe deposit boxes, international banking services, night depository facilities, foreign exchange, and wire transfers. In addition, the company offers wealth management products and services that include non-deposit investment products, annuities, insurance, investment management, asset custody and general consultation, and planning services. Central Pacific Financial Corp. was founded in 1954 and is headquartered in Honolulu, Hawaii.

Central Pacific Financial Corp New

CITIC ( ($HK:0267) ) just unveiled an announcement. CITIC Limited has alerted investors to the strong preliminary first-quarter 2026 results of its...

CITIC Securities Posts Strong Preliminary Q1 2026 Earnings Surge

JTC PLC ( ($GB:JTC) ) has provided an announcement. JTC PLC reported strong full-year 2025 results, with revenue up 25.1% to £381.9m, underlying EB...

JTC posts strong 2025 results as £2.7bn takeover advances

Bernstein analyst Stacy Rasgon maintained a Buy rating on HOYA today and set a price target of Yen31,500.00. Rasgon covers the Technology sector, f...

Bernstein Sticks to Its Buy Rating for HOYA (HOCPF)

DCC plc ( ($GB:DCC) ) has issued an update. DCC plc has reported that, as of 31 March 2026, it has 87,609,229 issued ordinary shares of €0.25 each,...

DCC Updates Share Capital and Voting Rights for Regulatory Disclosures

The latest announcement is out from Inchcape ( ($GB:INCH) ). Inchcape plc has confirmed that its issued share capital stands at 356,454,027 ordinar...

Inchcape Confirms Total Voting Rights and Share Capital Structure

An update from Inchcape ( ($GB:INCH) ) is now available. Inchcape has repurchased 414,529 ordinary shares between 23 and 27 March 2026 as part of i...

Inchcape Cancels Further Shares as Buyback Nears £14m

GF Securities analyst maintained a Buy rating on CITIC yesterday and set a price target of HK$14.51. Currently, the analyst consensus on CITIC is a...

GF Securities Remains a Buy on CITIC (CTPCF)

CITIC ( ($HK:0267) ) has shared an announcement. CITIC Limited issued a supplemental announcement to its 2025 annual results release, clarifying th...

CITIC Issues Supplemental Note Clarifying Status of 2024–2025 Financial Results

The latest announcement is out from CITIC ( ($HK:0267) ). CITIC Limited has declared a final ordinary dividend of RMB 0.385 per share for the finan...

CITIC Declares Final 2025 Dividend of RMB 0.385 Per Share

CITIC ( ($HK:0267) ) has shared an announcement. CITIC Limited announced that independent non-executive director Gregory Lynn Curl will resign from...

CITIC Reshapes Nomination Committee as Gregory Curl Resigns and Chen Yuyu Steps Up

The latest announcement is out from InnoCare Pharma Ltd. ( ($HK:9969) ). InnoCare Pharma has proposed amendments to its existing memorandum and art...

InnoCare Pharma Moves to Modernize Governance With New Corporate Charter

An announcement from InnoCare Pharma Ltd. ( ($HK:9969) ) is now available. InnoCare Pharma Limited has formalized the terms of reference for its au...

InnoCare Tightens Audit Committee Rules to Bolster Governance

InnoCare Pharma Ltd. ( ($HK:9969) ) has shared an update. InnoCare Pharma’s board has formalized detailed terms of reference for its Compensation C...

InnoCare Pharma Tightens Governance With Formal Compensation Committee Mandate

InnoCare Pharma Ltd. ( ($HK:9969) ) just unveiled an announcement. InnoCare Pharma Limited has formalized and disclosed the terms of reference for ...

InnoCare Pharma Updates Nomination Committee Governance Framework

The latest update is out from Inchcape ( ($GB:INCH) ). Inchcape plc has announced a boardroom change, with director Juan Pablo Del Río set to step ...

Inchcape Reshapes Board as Del Río Family Representation Continues

An update from CITIC ( ($HK:0267) ) is now available. CITIC Limited has announced that its key subsidiary, China CITIC Bank, has released audited a...

China CITIC Bank Releases 2025 Results and Proposes Stable Cash Dividend

An announcement from CITIC ( ($HK:0267) ) is now available. CITIC Limited has scheduled a board meeting for 27 March 2026 to approve the annual res...

CITIC Sets March Board Meeting to Approve 2025 Results and Consider Final Dividend

The latest update is out from InnoCare Pharma Ltd. ( ($HK:9969) ). InnoCare Pharma has scheduled a board meeting for 25 March 2026 to review and ap...

Current Quarter	$0.77	Next Quarter	$0.77
Current Year	$3.28	Next Year	$3.63
QoQ Growth	+0.0%	YoY Growth	+10.7%
3Y EPS CAGR	N/A	Target Price	$37.50
Consensus	Buy	Upside	+10.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CPF	$33.92	0.00%	142.68K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CPF	$33.92	0%	142.68K
3
4
5
6

CPF

CPF

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Central Pacific Financial Corp New Data in Excel

Get Central Pacific Financial Corp New Data in Excel